Although the number of regenerative medicine therapies that have been approved is rapidly increasing, it is still very small in comparison to the number of treatments being advertised as ‘regenerative medicine’. Whether it’s via pay-to-participate clinical trials or clinics advertising dubious treatments, unproven therapies in regenerative medicine is big business. However, patients could be at risk of, at best, wasting their money – at worst, they could be putting themselves in harm’s way.
In this section of the Patient Zone, discover the latest research into unproven therapies in regenerative medicine, from online markets around the world to navigating the ethics of providing or accessing unproven therapies. Plus, read the latest news in the field.